Wednesday, October 14, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 27, 2026

Investors Hated This Amazon Announcement in February. Now It Looks Genius.

View original at nasdaq.com
“For reference, Amazon's trailing-12-month free cash flow peaked at $53 billion in mid-2024.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • A $1,000 investment in Apple when Stock Advisor doubled down in 2008 would be worth $51,615 as of April 26, 2026.

    60% confidence
  • Over the long run, Amazon should generate even more free cash flow than before the AI investment cycle, exceeding the prior TTM peak of $53 billion reached in mid-2024.

    60% confidence
  • A $1,000 investment in Netflix when Stock Advisor doubled down in 2004 would be worth $498,522 as of April 26, 2026.

    60% confidence
  • Amazon's $200 billion capex plan is not a top-line revenue grab; management has confidence the investments will yield strong returns on invested capital.

    60% confidence
  • Mythos is too dangerous to release to the public; it will instead be offered with limited access to select enterprises to secure their codebases before any broader release.

    60% confidence
  • Amazon stock is still fairly attractive at the current price given the long-term opportunity to accelerate AWS and produce massive free cash flow by the end of the decade.

    60% confidence
  • A $1,000 investment in Nvidia when Stock Advisor doubled down in 2009 would be worth $540,224 as of April 26, 2026.

    60% confidence
  • Amazon is monetizing AWS capacity as quickly as it is installed.

    60% confidence
  • Amazon's massive jump in capex spending in 2026 could result in negative free cash flow for the business in 2026.

    60% confidence
  • Much of AWS capex expected to be spent in 2026 will be monetized in 2027-2028, and Amazon already has customer commitments covering a substantial portion of that capex.

    60% confidence
  • AWS's AI-specific revenue reached a $15 billion annual run rate earlier in 2026 and is growing extremely quickly.

    60% confidence

Data points we hold from this source

OpenAI · aws spend commitment100 USD
Anthropic · aws spend commitment100 USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com